Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Daniel E. Geffken Insider Profile
4 Followers
Daniel E. Geffken, Director at Windtree Therapeutics, holds 2.17K shares in Windtree Therapeutics (Ticker: WINT), holds 50.00K shares in Eloxx Pharmaceuticals (Ticker: ELOX), holds ― shares in CalciMedica (Ticker: CALC).
Daniel E. Geffken Windtree Therapeutics (WINT)Director
Windtree Therapeutics (WINT)
Director
Ranked #89,011 out of 98,042 Corporate Insiders
Profitable Transactions
0 out of 2 Profitable Transactions
Average Return
-80.40%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Daniel E. Geffken holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:May 27, 2020 - May 27, 2021
Return:-74.20%
The most profitable trade made by Daniel E. Geffken
Daniel E. Geffken's Trading History
Windtree Therapeutics
Aug 29, 2023
Director
Uninformative Buy
―
$7.85K
Eloxx Pharmaceuticals
Dec 01, 2021
INTERIM CFO
Informative Buy
36.00K
$35.00K
CalciMedica
―
Interim CFO
―
―
CERo Therapeutics Holdings
Feb 16, 2024
Chief Financial Officer
Uninformative Buy
―
$2.00K
List of latest transactions for each holding click on a transaction to see Daniel E. Geffken's performance on stock
You May Also Like
Daniel E. Geffken insider profile FAQ
What is the percentage of profitable transactions made by Daniel E. Geffken?
The percentage of profitable transactions made by Daniel E. Geffken is 0%.
What is the average return per transaction made by Daniel E. Geffken?
The average return per transaction made by Daniel E. Geffken is -80.40%.
What stocks does Daniel E. Geffken hold?
Daniel E. Geffken holds: WINT, ELOX, CALC, CERO stocks.
What was Daniel E. Geffken’s latest transaction?
Daniel E. Geffken latest transaction was an Uninformative Buy of ―.
What was Daniel E. Geffken's most profitable transaction?
Daniel E. Geffken’s most profitable transaction was an Informative Buy of WINT stock on May 27, 2020. The return on the trade was -74.20%.
What is Daniel E. Geffken's role in Windtree Therapeutics?
Daniel E. Geffken's role in Windtree Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.